Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin.
Saved in:
| Title: | Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin. |
|---|---|
| Authors: | Howell, Matthew1,2,3, Gibb, Adam1,2, Radford, John1,2,4, Linton, Kim1,2,4 kim.m.linton@manchester.ac.uk |
| Source: | British Journal of Haematology. Dec2017, Vol. 179 Issue 5, p841-843. 3p. 2 Charts. |
| Database: | Academic Search Ultimate |
| ISSN: | 00071048 |
|---|---|
| DOI: | 10.1111/bjh.14257 |
